Aaron_TFS
Team TFS
Team TFS
since ‎05-03-2021
‎04-26-2023

User Statistics

  • 38 Posts
  • 1 Solutions
  • 19 Kudos given
  • 46 Kudos received

User Activity

AAV Vectors for Gene Therapy: Top Questions Answered

04-26-2023
Advances in genetics and bioengineering have enabled the development of gene therapy to treat diseases caused by recessive gene disorders, acquired genetic diseases, and some viral infections. Technologies for the manufacture and analysis of gene the...

Genome packaging efficiency using native mass spectrometry to characterize AAV capsids

04-21-2023
Knowing the genome packaging efficiency during adeno-associated virus (AAV) manufacturing is a crucial step toward the successful clinical application of next-generation biotherapeutics. In recent years, recombinant AAV production has been steadily o...

Gene therapy: Using size exclusion chromatography to evaluate AAV product titers

04-18-2023
Production of recombinant adeno-associated viruses (AAVs) for the purpose of gene therapy is challenging and requires various analytical assays to monitor product quality attributes (PQAs) such as product titer. Due to low production yields, it’s imp...

Oligonucleotide Therapeutics: A Biopharmaceutical Basics Overview

01-30-2023
This is the fourth blog post in the Biopharmaceutical Basics series. Over the past 30 years, noteworthy progress has been made in the field of oligonucleotide therapeutics, beginning with antisense oligonucleotides (ASOs) and aptamers, followed by si...

Gene Therapy: A Biopharmaceutical Basics Overview

01-25-2023
This is the third blog post in the Biopharmaceutical Basics series. Sometimes the whole or part of a gene is defective or missing from birth. This is typically referred to as a genetically inherited mutation. In addition, healthy genes can change (mu...
View more
Kudos given to
united states flag icon United States